Esperion Therapeutics Inc (ESPR) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ESPR Annual Balance Sheets →
Quarterly balance sheet trends provide context on Esperion Therapeutics Inc's liquidity, leverage, and long-term financial structure.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent156.16
Cash & Short-term Investments156.00
Accounts receivable132.35
Inventories104.21
Other Current Assets60.72
Prepaid Expense And Other Assets Current6.02
Total Current Assets459.46
Equipment/Property/Plant Net0.31
Intangible Assets0.06
Prepaid Clinical Development Costs Current5.79
Operating Lease Right Of Use Asset2.70
Total Assets462.53
Liabilities
Accounts Payable, Current AC68.41
Convertible Notes Payable, Current NO0.00
Other Liabilities, Current231.95
Total Current Liabilities300.36
Other Long-term Debt, Noncurrent OT152.67
Convertible Notes Payable, Noncurrent LO97.39
Total Long-term Debt250.07
Other liabilities, Noncurrent220.03
Accrued Clinical Development Costs Current2.68
Contract With Customer Liability Current43.53
Operating Lease Liability Current1.70
Operating Lease Liability Noncurrent0.86
Total Liabilities770.46
Stockholders' Equity
Treasury Stock Common Value-55.00
Common Stock Value0.26
Additional Paid In Capital Common Stock1,395.72
Retained Earnings / Accumulated Deficit-1,648.91
Other Equity0.00
Common Stockholder's Equity-307.93
Total Stockholder's Equity-307.93
Liabilities & Stockholder's Equity462.53
4 historic quarters locked

Sign in to unlock the full Esperion Therapeutics Inc balance sheet history.

About Esperion Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-032870

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.